The company sold 16.9m new shares, and existing shareholders sold 21.6m, shares for 575p each.
That is a premium to the most commonly referenced peer, NMC Health, on a 2013 price/earnings multiple, and an EV/Ebitda basis.
At issue price, Al Noor is around 15.5 times on the former, ...Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.